Direkt zum Inhalt
Merck
HomeLysis & Protein ExtractionProtease Inhibitor Cocktails

Protease Inhibitor Cocktails

Our complete collection of Protease Inhibitor Cocktails offers a diverse portfolio that accommodates your different sample needs. Specialized cocktails are available for various sample forms:

  • Bacterial cells
  • Mammalian tissues and cells
  • Plant tissues and cells
  • Histdine-tagged (HIS-tagged) proteins.

Our portfolio also includes protease inhibitor cocktails that are tailored to specific applications:

  • We offer cocktails for customers who require animal component-free (ACF) protease inhibitor cocktails in their work.
  • We also now offer the only fully mass spectrometry-compatible protease inhibitor cocktail and phosphatase inhibitor cocktail on the market, MSSAFE.

Our Protease Inhibitor Cocktails have been optimized to maintain and preserve protein functionality following cell lysis, and are available in powder, solution, or tablet forms. Component information for our cocktails is available in the table below:

Protease Inhibitor Cocktails

Product NumberP2714S8820P1860P8465P8340
General
Use
General
Use
Tissue
Culture
Bacterial
Cells
Mammalian
Tissues
Lyophilized
powder -
Water
Soluble
Tablet -
Water
Soluble
Solution
in
DMSO
Lyophilized
powder -
Vial of
DMSO
Solution
in DMSO
AEBSF
Aprotinin
Bestatin
EDTA
E-64
Leupeptin
Pepstatin A
Phosphoramidon
1,10-Phenanthroline
Elastinal
Nafamostat mesylate
Antipain
Product NumberP8849S8830P8215P9599I3911I3786MSSAFE
Histidine-
Tagged
Proteins
Histidine-
Tagged
Proteins
Fungal/
Yeast
Cells
Plant
Cells
General
Use
(Animal
Component
Free/ACF)
Mammalian
Cells and
Tissues
(Animal
Component
Free/ACF)
Mammalian
Cells and
Tissues
Solution
in DMSO
Tablet -
Water
Soluble
Solution
in DMSO
Solution
in DMSO
Lyophilized
powder
(water
soluble)
Solution
in DMSO
Lyophilized
powder
(water
soluble)
AEBSF
Aprotinin
Bestatin
EDTA
E-64
Leupeptin
Pepstatin A
Phosphoramidon
1,10-Phenanthroline
Elastinal
Nafamostat mesylate
Antipain
Melden Sie sich an, um fortzufahren.

Um weiterzulesen, melden Sie sich bitte an oder erstellen ein Konto.

Sie haben kein Konto?